Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - adalimumab, quantity: 40 mg - injection, solution - excipient ingredients: sodium chloride; sucrose; polysorbate 80; water for injections - rheumatoid arthritis,adalicip is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. adalicip can be used alone or in combination with methotrexate.,juvenile idiopathic arthritis,polyarticular juvenile idiopathic arthritis,adalicip in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older weighing greater than or equal to 30 kg who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (dmards). adalicip can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,enthesitis-related arthritis,adalicip is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,psoriatic arthritis,adalicip is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous dmards has been inadequate.,ankylosing spondylitis,adalicip is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. crohn?s disease in adults and children (greater than or equal to 6 years; weighing greater than or equal to 40 kg) adalicip is indicated for the treatment of moderate to severe crohn?s disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients; ? who have had an inadequate response to conventional therapies or, ? who have lost response to or are intolerant to infliximab,ulcerative colitis,adalicip is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time (see section 5.1 pharmacodynamic properties -clinical trials).,psoriasis in adults and children,adalicip is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,adalicip is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age weighing greater than or equal to 40 kg who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,hidradenitis suppurativa in adults and adolescents (from 12 years of age),adalicip is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,uveitis,adalicip is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - adalimumab, quantity: 40 mg - injection, solution - excipient ingredients: sodium chloride; sucrose; polysorbate 80; water for injections - rheumatoid arthritis,adalicip is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. this includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate. adalicip can be used alone or in combination with methotrexate.,juvenile idiopathic arthritis,polyarticular juvenile idiopathic arthritis,adalicip in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older weighing greater than or equal to 30 kg who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (dmards). adalicip can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,enthesitis-related arthritis,adalicip is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,psoriatic arthritis,adalicip is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous dmards has been inadequate.,ankylosing spondylitis,adalicip is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. crohn?s disease in adults and children (greater than or equal to 6 years; weighing greater than or equal to 40 kg) adalicip is indicated for the treatment of moderate to severe crohn?s disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients; ? who have had an inadequate response to conventional therapies or, ? who have lost response to or are intolerant to infliximab,ulcerative colitis,adalicip is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time (see section 5.1 pharmacodynamic properties -clinical trials).,psoriasis in adults and children,adalicip is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,adalicip is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age weighing greater than or equal to 40 kg who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,hidradenitis suppurativa in adults and adolescents (from 12 years of age),adalicip is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,uveitis,adalicip is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ezycrop pty ltd - imidacloprid - suspension concentrates for seed treatment (fs) - imidacloprid guanidine active 600.0 g/l - insecticide - canola | cereal crop | clover pasture | cotton | forage brassicae | forage crop | lupin | maize | pasture - seed | sorghum | sun - aphid | barley yellow dwarf virus | black field earwig | black sunflower scarab | blue oat or pea mite | brown flea beetle | corn aphid | eastern false wireworm | field cricket | redlegged earth mite | southern false wireworm | striate false wireworm | sugarcane wireworm | thrip | wheat aphid | wingless cockroach | wireworm | calolampra elegans | calolampra solida | cosmozosteria spp. | false wireworm | large false wireworm | oat aphid | red legged earth mite | telegryllus commodus | thrips spp.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

conquest crop protection pty ltd - imidacloprid - suspension concentrates for seed treatment (fs) - imidacloprid guanidine active 600.0 g/l - insecticide - canola | cereals | clover pasture | cotton | fescue seed crop | forage brassicae | kale (chou moellier) | lupin | maize | medic - aphid | barley yellow dwarf virus | black field earwig | black sunflower scarab | blue oat or pea mite | brown flea beetle | corn aphid | eastern false wireworm | field cricket | redlegged earth mite | southern false wireworm | striate false wireworm | sugarcane wireworm | thrip | wheat aphid | wingless cockroach | wireworm | calolampra elegans | calolampra solida | cosmozosteria spp. | false wireworm | large false wireworm | oat aphid | red legged earth mite | telegryllus commodus | thrips spp.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - metalaxyl-m; sedaxane; difenoconazole - suspension concentrates for seed treatment (fs) - metalaxyl-m phenylamide active 16.5 g/l; sedaxane pyrazole active 13.8 g/l; difenoconazole triazole active 66.2 g/l - fungicide - barley | oats | triticale | wheat - covered smut - u. segetum var. segetum | covered smut (bunt) - tilletia spp. | flag smut on cereal | loose smut - ustilago avenae | loose smut - ustilago tritici | loose smut (ustilago spp.) - suppression | rhizoctonia brown patch | root rot - phytophthora spp. | spot form net blotch - pyrenophora teres | bare patch | bunt | common bunt | rhizoctonia solani | seedborne flag smut | soilborne flag smut | suppression | ustilago nuda (tritici)

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vet med ip pty ltd - povidone-iodine; iodophor - topical cream, ointment, paste, gel, lotion - povidone-iodine emulsifiers & surfactants active 15.0 g/l; iodophor mineral-iodine active 6.0 g/l - dermatological preps. - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - anti-infective or antiseptic | dermatoses | eczema | fungal infection | girth itch | greasy heel | queensland itch | ringworm - microsporum spp. | ringworm - trichophyton spp. | saddle acne | superficial wounds | bacterial infections | conjunctivitis | control infection | eye infections | eye-washes | hypersensitivity to culicoides | keratoconjunctivitis | microsporosis | ocular infections | trichophytosis

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - cypermethrin; triticonazole - suspension concentrates for seed treatment (fs) - cypermethrin pyrethroid active 4.0 g/l; triticonazole triazole active 200.0 g/l - mixed function seed treat - barley | wheat - covered smut (bunt) - tilletia spp. | flag smut on cereal | granary weevil | leaf rust (p. recondita) - suppression | leaf scald - suppression | lesser grain borer | loose smut - ustilago tritici | powdery mildew - suppression | rice weevil | rust-red flour beetle | sawtoothed grain beetle | smut - ustilago segetum var hordei | stripe rust - suppression | tropical warehouse moth | bunt | common bunt | covered smut | grain borer | seedborne flag smut | seedling infections | soilborne flag smut

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - imidacloprid - suspension concentrates for seed treatment (fs) - imidacloprid guanidine active 600.0 g/l - insecticide - brassica forage crop | canola | cereal crop | clover pasture | cotton | lupin | maize | pasture seed and forage crops | sorghum - aphid | barley yellow dwarf virus | black field earwig | black sunflower scarab | blue oat or pea mite | brown flea beetle | corn aphid | eastern false wireworm | field cricket | redlegged earth mite | southern false wireworm | striate false wireworm | sugarcane wireworm - agrypnus variabilis | thrip | wheat aphid | wingless cockroach | wireworm | calolampra elegans | calolampra solida | cosmozosteria spp. | false wireworm | large false wireworm | oat aphid | red legged earth mite | telegryllus commodus | thrips spp.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - imidacloprid - suspension concentrates for seed treatment (fs) - imidacloprid guanidine active 600.0 g/l - insecticide - canola | cereals | clover pasture | cotton | forage brassicae | lupin | maize | pasture seed and forage crops | sorghum | sunflo - aphid | barley yellow dwarf virus | black field earwig | black sunflower scarab | blue oat or pea mite | brown flea beetle | corn aphid | eastern false wireworm | field cricket | redlegged earth mite | southern false wireworm | striate false wireworm | sugarcane wireworm | thrip | wingless cockroach | wireworm | calolampra elegans | calolampra solida | cosmozosteria spp. | false wireworm | large false wireworm | red legged earth mite | telegryllus commodus | thrips spp.

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wholesale horticultural group pty ltd - phosphorous (phosphonic) acid present as mono & di potas - soluble concentrate - phosphorous (phosphonic) acid present as mono & di potas mineral-phosphorus acid active 200.0 g/l - fungicide - avocado | citrus - mature, well established | citrus - young or small | grape | ornamental | subterranean clover pasture | carna - brown rot - phytophthora citrophthora | collar rot - phytophthora citrophthora | collar rot - phytophthora nicotianae | downy mildew on grape | phytophthora root rot | root rot - p. nicotianae var. parasitica | root rot - phytophthora clandestina | phytophthora blight | phytophthora root rot | soil fungi